These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 185504)

  • 1. [The effect of etiroxate on serum lipids after myocardial infarction or in angina pectoris].
    Schwartzkopff W; Hoffmann H; Nijssen J; Etzel V
    Med Klin; 1976 Sep; 71(38):1555-63. PubMed ID: 185504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of hyperlipoproteinaemia, types IIa and IIb, with etiroxate (author's transl)].
    Schwartzkopff W; Russ E
    Dtsch Med Wochenschr; 1975 Apr; 100(15):815-21. PubMed ID: 164334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of hypercholesterolemia after myocardial infarction with D-thyroxine (author's transl)].
    Bommer J; Speders H; Ehrke V
    MMW Munch Med Wochenschr; 1975 Jan; 117(4):139-42. PubMed ID: 803622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expeimental studies in animals on a new lipid lowering compound: etiroxate hydrochloride (author's transl)].
    Beckmann R
    Arzneimittelforschung; 1979; 29(3):499-508. PubMed ID: 582735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
    Banz H; Gall FP
    Fortschr Med; 1979 Nov; 97(42):1942-1947. PubMed ID: 520990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of primary hyperlipoproteinemia type IIa and IIb with dextrothyroxine (author's transl)].
    Koschinsky T; Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1974 Mar; 99(11):494-6. PubMed ID: 4365046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of primary lipoproteinemia type IIa and IIb with highly purified dextro-thyroxine (D-T4). Controlled study in ambulant conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1974 Mar; 99(11):487-93. PubMed ID: 4365703
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lipid studies in myocardial infarct, angina pectoris and obliterating arteriosclerosis].
    Rechenberger J; Kröning G
    Z Gesamte Inn Med; 1973 Dec; 28(23):728-33. PubMed ID: 4362267
    [No Abstract]   [Full Text] [Related]  

  • 12. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The serum triglycerides and their role as a coronary risk factor (author's transl)].
    Pristautz H; Pavek P; Klein W
    Z Kardiol; 1977 May; 66(5):216-9. PubMed ID: 878547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J; Schwartzkopff W; Zschiedrich M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():392-5. PubMed ID: 206057
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the lipid-lowering agent, procetofen, on the makeup of human biliary lipids].
    Grandjean EM; Mordasini R; Paumgartner G
    Schweiz Med Wochenschr; 1979 Apr; 109(16):601-2. PubMed ID: 219470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol of alpha and beta lipoproteins in ischemic heart disease.
    Alvarado M; Méndez D; Rivera-Hidalgo PR
    Arch Invest Med (Mex); 1981; 12(4):589-98. PubMed ID: 7332395
    [No Abstract]   [Full Text] [Related]  

  • 20. [D-thyroxin in the therapy of type IIa and IIb hyperlipoproteinemias].
    Hempel RD; Müller G; Burchardt U
    Z Gesamte Inn Med; 1977 Jun; 32(11):suppl 175-6. PubMed ID: 201111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.